For the Media
Dr. Edus Hootie Warren is a member of Fred Hutch's Clinical Research Division and a researcher in the Program in Immunology. His laboratory is focused on cancer immunology and understanding the mechanisms and molecules that mediate graft-versus-host disease (GVHD) and graft-versus-tumor (GVT) activity after allogeneic hematopoietic transplants. Dr. Warren is also an oncologist specializing in trating patients with leukemia, lymphoma and multiple myeloma.
Overview of Edus Houston Warren Research/Clinical Focus
His overall research focus is cancer immunology and clinical expertise is treating patients with blood cancers.
Edus Houston Warren - Brief Curriculum Vitae
Appointments, affiliations and researcher interests
The overall focus of the Warren laboratory is cancer immunology – with a particular interest in the cellular and molecular mechanisms that mediate cancer regression after immune-based therapy.
Program in Immunology
Researchers are learning how to empower a patient’s own immune system to do what it does naturally — fight disease. They continue discovering new ways to give the immune cell army the upper hand against cancer and learning how immune cells respond to disease and how to safely enhance immune responses to better control, cure and potentially prevent cancers and other serious diseases.
Clinical Research Division
Researchers conduct laboratory and patient-oriented research to better understand the mechanisms that drive cancer and other human diseases. Integrating a variety of disciplines, our investigators are continually developing new therapeutic approaches and leading clinical trials that help move discoveries from laboratory to patient. Our pioneering research has saved hundreds of thousands of lives.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first National Cancer Institute-funded cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.